Fresenius Medical Care | FME - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Akzo Nobel EUR 251M 3M 2026-06
Alcon AG USD 297M 16M 2026-03
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 827M 2.7B 2026-06
Beiersdorf EUR 504M 312M 2025-12
DaVita Healthcare Partners USD 570.82M 97.27M 2026-06
Demant DKK 2.12B 35M 2026-06
E.ON EUR 4.11B 3.05B 2026-03
Essilor EUR 2.3B 919M 2026-06
Fresenius EUR 719M 118M 2026-06
Fresenius Medical Care EUR 537.27M 269.27M 2026-06
Genmab DKK 407M 182M 2026-06
Getinge SEK 1.35B 268M 2026-06
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.6B 312M 2026-06
GN Store Nord DKK -68M 638M 2026-03
GRIFOLS EUR 329M 80M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 673M 243M 2025-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 4.75B 515M 2026-06
Philips EUR 610M 308M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
RWE EUR -139M 716M 2026-03
Sanofi EUR 2.38B 449M 2026-06
SAP EUR 2.64B 11.13B 2026-06
Smith & Nephew USD 505M 65M 2026-06